Inventor · disambiguated record
Scott Savage
Also filed as: SAVAGE SCOTT · SAVAGE SCOTT J
17 granted patents·16 pending applications·53 citations·filing 2005–2023
92Inventor score
Top patents by PatentIndex Score
33 records- 0193US11028100B2Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of productionGENENTECH INC·Filed 2020·Granted Jun 8, 2021·3 cites·25 claims
- 0291US9315471B2Process of making hydroxylated cyclopentapyrimidine compounds and salts thereofGENENTECH INC·Filed 2013·Granted Apr 19, 2016·12 cites·16 claims
- 0389US10781219B2Process for the preparation of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[F]imidazo[1,2-D][1,4]oxazepin-9-yl)amino) propanamideGENENTECH INC·Filed 2019·Granted Sep 22, 2020·5 cites·20 claims
- 0489US7888364B2Pyridyl inhibitors of hedgehog signallingCURIS INC·Filed 2005·Granted Feb 15, 2011·10 cites·55 claims
- 0586US9290458B2Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereofGENENTECH INC·Filed 2013·Granted Mar 22, 2016·4 cites·44 claims
- 0686US2024116872A1Pyridyl inhibitors for hedgehog signallingGENENTECH INC·Filed 2023·Application pending·0 cites
- 0783US11591345B2Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of productionGENENTECH INC·Filed 2020·Granted Feb 28, 2023·1 cites·18 claims
- 0883US2023265054A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2023·Application pending·0 cites
- 0982US9505725B2Crystalline and mesomorphous forms of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereofGENENTECH INC·Filed 2016·Granted Nov 29, 2016·2 cites·17 claims
- 1082US8431694B1Process for making thienopyrimidine compoundsGENENTECH INC·Filed 2012·Granted Apr 30, 2013·5 cites·1 claims
- 1181US9321761B2Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2014·Granted Apr 26, 2016·3 cites·26 claims
- 1279US12410189B2Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9- yl)amino)propanamide, and methods of productionGENENTECH INC·Filed 2023·Granted Sep 9, 2025·0 cites·18 claims
- 1377US9278961B2Pyridyl inhibitors of hedgehog signallingGUNZNER JANET L·Filed 2010·Granted Mar 8, 2016·4 cites·93 claims
- 1475US9790183B2Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2016·Granted Oct 17, 2017·1 cites·49 claims
- 1575US8354528B2Process for making thienopyrimidine compoundsGENENTECH INC·Filed 2008·Granted Jan 15, 2013·2 cites·5 claims
- 1675US2021070707A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2020·Application pending·0 cites
- 1771US10457648B2Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Oct 29, 2019·1 cites·14 claims
- 1869US2020010420A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2019·Application pending·0 cites
- 1969US2020190030A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2020·Application pending·0 cites
- 2068US10870626B2Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compoundsHOFFMANN LA ROCHE·Filed 2019·Granted Dec 22, 2020·0 cites·8 claims
- 2168US2009281089A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2009·Application pending·0 cites
- 2266US10806735B2Use of neutrophil elastase inhibitors in liver diseasePH PHARMA CO LTD·Filed 2019·Granted Oct 20, 2020·0 cites·4 claims
- 2365US2015111879A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2014·Application pending·0 cites
- 2464US2018029984A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2017·Application pending·0 cites
- 2564US2018258043A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2018·Application pending·0 cites
- 2661US2024228493A1Lrrk2 inhibitors and uses thereofNEURON23 ICN·Filed 2023·Application pending·0 cites
- 2761US2024208972A1Lrrk2 inhibitors and uses thereofNEURON23 INC·Filed 2023·Application pending·0 cites
- 2860US2017015627A1Pyridyl inhibitors of hedgehog signallingGENENTECH INC·Filed 2016·Application pending·0 cites
- 2958US2021069192A1Use of neutrophil elastase inhibitors in liver diseasePH PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3058US2018339997A1Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of productionGENENTECH INC·Filed 2018·Application pending·0 cites
- 3153US2012094980A1Pyridyl inhibitors of hedgehog signallingGUNZNER JANET L·Filed 2011·Application pending·0 cites
- 3251US9975856B2Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acidGENENTECH INC·Filed 2016·Granted May 22, 2018·0 cites·13 claims
- 3347US2023373985A1Kinase modulators and methods of use thereofORIGENIS GMBH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Savage files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →